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Patients with cardiac sarcoidosis may present
with clinical and morphological features similar to
ARVD or cardiomyopathy [1]. Sarcoidosis is an
a chronic noncaseating granulomatous disease of
unknown cause, characterized by multisystemic
involvement. Practically no organ is immune to sar-
coidosis; most commonly, in up to 90% of patients,
it affects the lungs [2]. The most commonly invo-
lved organ in sarcoid related death has been repor-
ted to be the lung in western countries, while it was
the heart in the Japanese autopsy series [3].
The diagnosis of myocardial sarcoidosis is diffi-
cult and frustrating. Its clinical manifestations depend
on the location and extent of granulomatous inflam-
mation, and the symptoms and signs range among
benign arrhythmias, heart block, intractable CHF,
intense chest pain, to fatal VF [4].
The ECG may be normal or reflect every de-
gree of block of the atrioventricular junction and
bundle of His and every type of arrhythmia along
with nonspecific ST-T-wave changes [5]. Other
common ECG findings are signs of hypercalcemia
(e.g. decreased QT interval), PR depression caused
by pericarditis, or ST elevation caused by ventri-
cular aneurysm. Premature ventricular complexes
and nonsustained ventricular tachycardia are also
common, seen by ECG in as many as 22% of pa-
tients with sarcoidosis. Sudden death from ventri-
cular tachycardia and heart block accounts for up
to 65% of deaths from cardiac sarcoidosis [6].
Cardiac sarcoidosis should be considered in all
young patients with unexplained conduction disor-
ders [7], CHF or in cases of SCD [8].
In extensive forms are frequently pseudo myo-
cardial infarction patterns with pathological Q wa-
ves on ECG [9].
MRI abnormalities, consisting of cardiac signal
intensity and thickness, with the following three
patterns:
— nodular;
— focal increase in signal on gadolinium diethylene-
triamine pentaacetic acid-enhanced, T1-weighted
images;
— focal increased signal on T2-weighted images
without gadolinium uptake.
The improvement or stability of the MRI fin-
dings is correlated with clinical features.
With corticosterotherapy, the MRI images im-
proved either partially or completely, whereas.
The cardiac MRI may find its usefulness as
a guide to obtaining EMB specimens and to moni-
toring the response of the disease to treatment.
The study is small and lacks a correlation of
myocardial histology with MRI features. However,
the study clearly calls for a large multicenter trial.
The most significant drawback of MRI is that
the patient with a pacemaker and/or automatic ICD
will not be able to take advantage of it. In such pa-
tients, 201Tl scanning remains the test for assessing
myocardial damage.
Cardiac PET using F-FDG under fasting con-
ditions is a promising technique for identification
of cardiac sarcoidosis and assessment of disease
activity. The metodology can detect the early sta-
ge of cardiac sarcoidosis, in which fewer perfusion
abnormalities and high inflammatory activity are
noted, before advanced myocardial impairment. The
sensitivity of fasting FDG PET in detecting cardiac
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sarcoidosis was 100%, significantly higher than that of
99mTc-MIBI SPECT (63.6%) or Ga scintigraphy  (36.3%).
The accuracy of fasting FDG PET was significantly
higher than Ga scintigraphy [10].
An EMB is preferable, but the procedure has
sensitivity as low as 20% [11]. Others author refer-
red sensitivity approximately of 50% thus, the search
for a safe, reliable, and easily available diagnostic test
for cardiac sarcoidosis continues. The pathological
feature is the presence of noncaseating granulomas
that eventually form fibrotic scars. Table 1 shows the
principal differences between the two entities.
Table 1. The principal differences between the two entities.
Cardiac sarcoidosis ARVD
Family history Absent. Present in 30% to 50% of cases.
When the disease is identified genetic
 screening should be performed
 among patient’s family members.
Gender (M/F) 1 to 1 2.9 to 1
Age at presentation Young or middle-aged adults. Adolescents and young adults, perhaps.
There are rare references in childhood
Multisystemic Yes. Sarcoidosis commonly involves No.
involvement the eye, causing uveitis, the lacrimal gland,
and the cranial nerves, including
 the optic nerve itself [12].
Chest pain Intense chest pain is referred. Sometime [13–15]. Based on the
 data of Chinese ARVD registry,
it is not uncommon that ARVD
patients have chest pain.
Clinical myocardial Possible. No.
restrictives features
Mitral regurgitation Is common. Only in late stage with involvement of LV.
Pseudo myocardial Frequent in extensive forms. No.
infarction patterns
on ECG
Chest roentgenogram Bilateral hiliar linphoadenopathy. Eventually RV cardiomegaly.
Pathological features Noncaseating granulomas that Typical fibro-fatty replacement of the
 eventually form fibrotic scars. From the RV myocardium on dysplasia triangle.
 histological studies, fat infiltration
 seems absent in cardiac sarcoidosis.
Lungs affectation In up to 90% of patients. No.
Cor pulmonale is frequent.
More comum cardiac LV free wall RVOT, RVIT,
sites involved and interventricular septum. and apex of RV.
Pericardial effusion Are not uncommon. Absent.
Improved MRI images Yes. No.
with corticosteroids
Extensive angiographic Ventricular aneurysm The best definition of ARVD is obtained
analysis. With right Are sometime  present [13]. Free by extensive angiographic analysis with
ventricular angiography wall of the right ventricle thin, measurement of oxygen saturation and
dyskinetic with dilation is possible [16].  pressure curves in different positions,
coronary angiography and biventricular
angiography in order to distinguish
between some in regard to right
ventricular involvement similar
cardiac entities [17].
Therapy with Sometimes are indicated [18]. No.
corticosteroids, Immunosuppressive
hydroxychloroquine, and anticytokine treatments
methrotexate or can be effective in severe systemic
cyclophosphamide sarcoidosis and should be considered
 in sight-threatening disease.
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